News

Richard J. Nowak, MD, MS, Yale School of Medicine, explains what some early myasthenia gravis symptoms are and their impact on research efforts.
In this first part of an interview with The American Journal of Managed Care ®, MINT trial principal investigator Richard J. Nowak, MD, MS, explains inebilizumab’s mechanism of action and how ...
On the Myasthenia Gravis Activities of Daily Living (MG-ADL) scale, the adjusted mean difference between inebilizumab and placebo scores was -2.8 points (95% CI -3.9 to -1.7, P=0.001) at 52 weeks in ...
Also, an “art show favorite, Richard Nowak, who hails from Westfield and uses oils, acrylics, and watercolors as mediums, will have his work, which he describes as having a realist style with an ...